🔗 Share this article

A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has taken down violative material and prohibited related keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at home.

Within minutes of joining one community, a seller posted contact information, where most transactions occur. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these communities, posts show black plastic parcels with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet authorized … may expose patients to potentially serious health risks”.